[1]
“EVALUATION THE INFLUENCE OF LIPOPROTEIN LIPASE GENE POLYMORPHISM ON ROSUVASTATIN TREATMENT OUTCOME IN PATIENTS WITH CORONARY ARTERY DISEASE IN AL NAJAF GOVERNORATE”, RJDNMD, vol. 31, no. 1, pp. 543–556, Mar. 2024, Accessed: May 18, 2024. [Online]. Available: https://jrdiabet.ro/index.php/RJDNMD/article/view/320